Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Spero Therapeutics Inc (NQ: SPRO )

1.280 -0.040 (-3.03%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 11, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 101,448
Open 1.320
Bid (Size) 1.280 (6)
Ask (Size) 1.290 (1)
Prev. Close 1.320
Today's Range 1.270 - 1.320
52wk Range 0.9900 - 2.040
Shares Outstanding 52,571,813
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
5 Value Stocks In The Healthcare Sector
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga

Performance

YTD
-26.44%
-26.44%
1 Month
+15.32%
+15.32%
3 Month
-3.76%
-3.76%
6 Month
-18.47%
-18.47%
1 Year
-24.71%
-24.71%

More News

Read More
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Recap: Spero Therapeutics Q3 Earnings
Via Benzinga
SPERO ALERT: Bragar Eagel & Squire, P.C. is Investigating Spero Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
4 Analysts Have This to Say About Spero Therapeutics
Via Benzinga
Spero Therapeutics's Earnings: A Preview
Via Benzinga
Earnings Scheduled For November 13, 2023
Via Benzinga
Earnings Outlook For Spero Therapeutics
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
HC Wainwright & Co. Maintains Buy Rating for Spero Therapeutics: Here's What You Need To Know
Via Benzinga
Earnings Scheduled For May 11, 2023
Via Benzinga
Spero Therapeutics's Earnings Outlook
Via Benzinga
Spero Therapeutics's Earnings: A Preview
Via Benzinga
Earnings Outlook For Spero Therapeutics
Via Benzinga
Earnings Scheduled For August 10, 2023
Via Benzinga
Recap: Spero Therapeutics Q1 Earnings
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Earnings Scheduled For March 30, 2023
Via Benzinga
Earnings Outlook For Spero Therapeutics
Via Benzinga
Earnings Scheduled For November 14, 2022
Via Benzinga
How Is The Market Feeling About Spero Therapeutics?
Via Benzinga
EXCLUSIVE: Top 10 Stocks Searched On Benzinga Pro In September: Where Do Tesla, Apple, Bed Bath & Beyond Rank?
Via Benzinga
This Analyst Slashes PT On Lyft By 68%, Plus Telsey Advisory Group Predicts $125 For Nike
Via Benzinga
Short Volatility Alert: Spero Therapeutics, Inc.
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.